JW Modifier Update: Have You Met the JW Modifier Usage Mandate?

Why This Topic Matters

Correct handling of discarded-drug reporting affects Medicare Part B claims compliance, documentation practices, and claim accuracy in outpatient and related settings.

Article Sections

1. Get the Basics Right

   Introduces the topic of reporting discarded drugs and biologicals under Medicare Part B. It summarizes the general framework and the documentation emphasis discussed in the article.

2. Know Where You Can Apply the JW Modifier

   Describes the settings and payment contexts discussed for this modifier, including outpatient and provider-based environments. It also notes the general types of drugs and claim situations referenced by the article.

3. Know When Not to Report the JW Modifier

   Reviews scenarios and payment situations in which the article says the modifier is not used. It covers broader billing contexts, packaging, and claim types referenced by CMS guidance.

4. Master the Fine Art of Filing Claims with JW

   Discusses claim-line reporting concepts for discarded drugs and the role of documentation when quantities cannot be readily quantified. It also addresses payment-window and inpatient-transition considerations mentioned in the article.

5. Keep a Watch on Change to Inpatient Status

   Focuses on the effect of an outpatient-to-inpatient status change on claim handling. It explains that the article connects this transition to broader payment and reporting considerations.